Ovarian cancer, version 3.2012. uri icon

Overview

abstract

  • These NCCN Guidelines Insights focus on the major updates for the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ovarian Cancer by describing how and why the new recommendations were made. The 6 update topics were selected based on recent important updates in the guidelines and on debate among panel members about recent clinical trials, and include: 1) screening, 2) diagnostic tests for assessing pelvic masses, 3) primary treatment using neoadjuvant chemotherapy, 4) primary adjuvant treatment using bevacizumab in combination with chemotherapy, 5) therapy for recurrent disease, and 6) management of drug/hypersensitivity reactions. These NCCN Guidelines Insights also discuss why some recommendations were not made (eg, panel members did not feel the new data warranted changing the guideline). See "Updates" in the NCCN Guidelines for Ovarian Cancer for a complete list of all the recent revisions.

publication date

  • November 1, 2012

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms

Identity

Scopus Document Identifier

  • 84871415258

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2012.0140

PubMed ID

  • 23138163

Additional Document Info

volume

  • 10

issue

  • 11